Life Science Conferences and Events in London

Each year, London hosts a number of important life sciences conferences that explore trends in biotech, medtech, pharmaceuticals and other related sectors. The following are some of the major annual life sciences conferences and events held in London.

Anglonordic Life Science Conference

The Anglonordic Life Science Conference is a one-stop opportunity for innovators and leaders in the biotech and medtech sectors to invest and collaborate. It is also an opportunity to discover the Anglo-Nordic biotech region. Starting in the 2015, the conference will replace the Anglonordic Biotech Conference and the Anglonordic Medtech Conference. The programme is divided into biotech and medtech components, with networking opportunities, panel discussions and keynote speakers.

An invitation-only event, the conference brings together decision markets from drug discovery, biotech and medtech companies from the UK, Scandinavia and around the world. Delegates may apply for an invitation. Some of Europe's largest investment firms and the world's big pharma companies are invited to the conference. Previous attendees have represented GE Healthcare, Merck, Wellcome Trust, AstraZeneca, Millipore, Wellington Partners, and many others.

Point of Care Conference

The annual Point of Care Conference explores marketing opportunities and technology trends. The conference is an opportunity to discuss the implementation of point of care technology and ways of improving service efficiency. It also provides insights into the future of point of care.

First organised in 2014, the event brings together the perspectives of key opinion leaders. It also features point of care users, regulators, pharmaceutical and biotech companies, and suppliers. The conference is designed for business development managers, chief science officers, hospital executives, physicians, pharmacists, clinical scientists, point of care executives, and policy makers. Discussions typically focus on quality control, diagnostics, legislation and the future of point of care technology.

Clinical Trials in CNS Conference

First organised in 2002, the Clinical Trials in CNS Conference attracts major pharmaceutical companies and practitioners. The event focuses on clinical trials related to the central nervous system (CNS). With people around the world living longer lives, neurodegenerative diseases are becoming more common. This conference provides delegates with insights into best practices in clinical trials and their design, as well as learning about leading methods of addressing challenges in CNS research. It is also an opportunity to learn about key areas of CNS research and clinical trials and hear about the latest therapies for major CNS disorders.

The annual conference is designed for CEOs, executive directors, team leaders and consultants in a variety of life science fields, including clinical trial management, research and development, clinical trial design, and other related fields. It is also a great learning and networking forum for individuals involved in the treatment of Parkinson's, Alzheimer's, dementia, multiple sclerosis (MS), depression, schizophrenia, and other CNS disorders.

Orphan Drugs & Rare Diseases Conference

The orphan drugs market is predicted to rise as pharmaceutical companies look to these solutions as a revenue stream. The annual Orphan Drugs & Rare Diseases Conference is an opportunity to discuss and share ideas about market access, pricing and reimbursement, regulatory requirements and patient engagement. The conference provides delegates with information on development pathways for orphan drugs, as well as ways of gaining early market access and enhancing patient recruitment.

The Orphan Drugs & Rare Diseases Conference attracts executives and practitioners involved in various aspects of the pharmaceuticals industry. Delegates are typically engaged in regulatory affairs, market access, medical affairs, patient advocacy, clinical research, manufacturing and brand management. The two-day conference combines panel discussions with featured speakers.

Advances & Progress in Drug Design Conference

The Advances & Progress in Drug Design Conference provides an opportunity to understand recent advances in drug design. The conference includes presentations on case studies from major pharmaceutical companies as well as sessions on fragment-, structure- and computer-based drug design. The event also provides networking opportunities for scientists, academics, researchers and practitioners in the drug design field.

The conference brings together executives from industry and academia, offering a forum for discussions about ways to address common challenges. It is designed especially for directors, executives, heads, senior managers and principle scientists. Participants are generally involved in drug design, research, pharmacology, drug discovery, molecular imaging, computational and medicinal chemistry, screening, clinical development, and other related fields.

Cell Culture & Bioprocessing Congress

The Cell Culture & Bioprocessing Congress attracts more than 170 delegates and features some 50 presentations, case studies and panel discussions. According to the conference's organisers, the value of the cell culture industry will be over $6 billion by 2018. The conference is an opportunity to bring together leading experts to discuss the sector's potential and growth. It is also an opportunity to explore ways of overcoming challenges in the industry. The conference is part of the annual Oxford Global Biologics Series, which includes the Proteins & Antibodies Congress, the Peptides Congress and the Biosimilars & Biobetters Congress.

The Cell Culture & Bioprocessing Congress focuses on key issues in cell line optimisation, process development and biological production. It also attracts leading biotech companies, academic institutions and pharmaceutical organisations. The event also includes one-to-one meetings, exhibitions and informal networking opportunities. Topics discussed during the two-day conference include cell line stability and authentication, scale-up improvements, contamination control, and batch management. It often features major solution providers in the industry, including Eppendorf, Hamilton, Merck Millipore, Solentim and UPM.